2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

A series of 2-(2-phenylmorpholin-4-yl)pyrimidin-4(3H)-ones was synthesized and examined for their inhibitory activity against glycogen synthase kinase-3β (GSK-3β). We found 21, 29 and 30 to possess potent in vitro GSK-3β inhibitory activity with good in vitro PK profiles. 21 demonstrated significant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2013-12, Vol.23 (24), p.6933-6937
Hauptverfasser: Fukunaga, Kenji, Uehara, Fumiaki, Aritomo, Keiichi, Shoda, Aya, Hiki, Shinsuke, Okuyama, Masahiro, Usui, Yoshihiro, Watanabe, Kazutoshi, Yamakoshi, Koichi, Kohara, Toshiyuki, Hanano, Tokushi, Tanaka, Hiroshi, Tsuchiya, Susumu, Sunada, Shinji, Saito, Ken-Ichi, Eguchi, Jun-ichi, Yuki, Satoshi, Asano, Shoichi, Tanaka, Shinji, Mori, Akiko, Yamagami, Keiji, Baba, Hiroshi, Horikawa, Takashi, Fujimura, Masatake
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of 2-(2-phenylmorpholin-4-yl)pyrimidin-4(3H)-ones was synthesized and examined for their inhibitory activity against glycogen synthase kinase-3β (GSK-3β). We found 21, 29 and 30 to possess potent in vitro GSK-3β inhibitory activity with good in vitro PK profiles. 21 demonstrated significant decrease of tau phosphorylation after oral administration in mice and excellent PK profiles.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2013.09.020